After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off over 4% in Wednesday trading, while the short term trend has not been favorable either.Some investors may now think that the bubble has burst for the high growth biotech sector, but there are actually still a few […]
Thinking about buying into biotech ahead of the JPMorgan Health Care Conference? History says the best play is to buy the day before the meeting starts and hold until the end.The JPMorgan conference, from Monday to Thursday, is the health industry’s biggest annual event, setting the agenda for the year. Sentiment out of the conference can dominate the first half […]
The first quarter of the year brought with it some major selling in the momentum names, specifically in biotech stocks.
Since then, the overall stock market has recovered, and so have most biotech stocks with it. Unfortunately, while the market has hit new highs, most biotechs have not.
Some biotech stocks, however, have performed better than others, and some have actually outperformed […]
